CTP Policy in the Real World: Mobile Wound Care, Compliance, and CMS Oversight

• CTP reimbursement reshaped access—and exposed vulnerabilities: Expanded CTP coverage revitalized mobile wound care but also fueled overutilization, misinformation, and regulatory backlash that now threatens appropriate access for post-acute patients.
• Policy assumptions don’t match mobile care realities: CMS policies and LCDs are largely written for controlled clinical environments, creating friction when applied to home- and SNF-based care where variability, patient adherence, and logistics are harder to control.
• The future favors mature, outcomes-driven models: Upcoming CMS changes signal a shift away from episodic, procedure-driven care toward disciplined patient selection, longitudinal management, and defensible clinical narratives—rewarding practices that invest in strong workflows, documentation, and interdisciplinary coordination now.

As cellular and tissue-based products (CTPs) reshape post-acute wound care, regulatory oversight has struggled to keep pace with real-world practice—particularly in mobile and home-based settings. In this CTP News Desk Q&A, Therese Laub, LPN, CWS, FACCWS, draws on years of post-acute experience to unpack how reimbursement shifts have shaped clinician behavior, where current CMS policies fall short, and what mobile wound care must do to remain compliant and sustainable. Her insights offer a candid look at where the field has been—and where it’s headed next.

You’ve witnessed multiple waves of change in wound care reimbursement and regulation. Looking specifically at CTPs, what policy shifts over the years have had the greatest practical impact on clinicians—and which lessons do you think regulators still haven’t fully absorbed?
 
I practice almost exclusively in the post-acute care space, and from that vantage point, CTPs are a relatively recent development, really becoming available around the time of the pandemic. Prior to that, mobile wound care did exist in areas like Chicago, where I practiced early on. At that time, reimbursement structures were sufficient to sustain mobile practices, though margins were modest. These models weren’t highly profitable, but they were viable and, most importantly, they filled a critical access gap for patients who could not easily get to outpatient wound centers.
 
One of the earliest policy shifts with major practical impact on clinicians came when reimbursement changed in a way that made mobile wound care financially unsustainable. As a result, I saw many practices shut down, not because the care wasn’t needed, but because the economics no longer supported it. The downstream impact was significant: patients lost access to specialized wound care, responsibility shifted to skilled home health agencies, and much of that care was delivered by nurses without advanced training in chronic wound management. Predictably, infection rates and hospitalizations increased, which then prompted additional layers of regulation in home health and post-acute settings. 
 
The introduction of CTP reimbursement marked another major policy shift—this time in the opposite direction. For the first time in years, reimbursement could both sustain mobile wound care and make it financially attractive again. That shift dramatically altered clinician behavior. We saw more providers enter the space, mobile models re-emerged, and for a period of time it appeared that comprehensive, at-home wound care was finally being realized for a population that desperately needed it. Unfortunately, hindsight has shown that this reimbursement expansion also fueled significant abuse, rapid market saturation, and behavior driven more by profit than by appropriate patient selection or clinical rigor.
 
The most striking aspect, however, has been how quickly CTP-related regulations have evolved in the post-acute space over the past two to three years. Policy changes around coverage, documentation, billing, and medical necessity have occurred at a pace that I feel has far outstripped provider education. Clinicians were left trying to interpret shifting LCDs, MAC guidance, and billing rules with little structured support. That confusion was compounded by what I observed as widespread misinformation, often driven by industry voices prioritizing utilization over education, which created a distorted understanding of what compliant CTP use actually required. By the time audits began in earnest, many practices were only just becoming aware of the regulatory frameworks governing their care.
 
The recent reimbursement reductions and tightened oversight were, in my view, inevitable and necessary. Regulators clearly needed to intervene. That said, the delay in addressing early warning signs allowed problems to escalate, and the eventual response may have overcorrected in ways that now risk limiting appropriate access. The key lesson regulators still have not fully absorbed is that chronic wound management is not a single intervention or isolated disease process. It is the ongoing management of multiple comorbid conditions such as vascular disease, diabetes, mobility limitations, nutrition, infection risk all interacting simultaneously.
 
Wound care continues to be regulated as though it were a narrow procedural service, rather than a complex specialty requiring longitudinal management and clinical judgment. Until regulatory frameworks fully reflect the breadth and complexity of chronic wound care, policy shifts will continue to swing between under-regulation and over-correction, rather than supporting sustainable, compliant, and patient-centered care models in the post-acute setting. 
 
Mobile wound care presents unique logistical and regulatory challenges. How do current CMS policies and LCD requirements for CTPs align—or conflict—with the realities of delivering advanced wound care in patients’ homes, SNFs, or other mobile settings?
 
Mobile wound care operates in fundamentally different conditions than the controlled environments many CMS policies and LCDs for CTPs appear to assume. In the post-acute and home-based setting, I have seen clinicians often delivering advanced wound care (including CTP application) without immediate clinical backup, consistent access to supplies, or ideal procedural environments. While LCD requirements are designed to promote safety, medical necessity, and appropriate utilization, they are largely written around an “ideal” care setting that does not always reflect the realities of mobile practice.
 
This creates points of tension. For example, documentation and monitoring expectations within CTP LCDs presume a level of environmental control, patient adherence, and consistency of care that is difficult to guarantee in the home or SNF setting. Clinicians may be fully compliant with clinical intent—appropriate patient selection, correct application, and ongoing assessment—yet still struggle to meet rigid documentation or progression benchmarks when factors such as limited space, variable infection control conditions, or patient non-adherence interfere with predictable outcomes.
 
Patient adherence further complicates alignment. CMS and LCDs assume full patient execution of  care plans that support wound progression and justify continued CTP use. In mobile settings, however, providers have limited ability to control off-visit behaviors, environmental risks, or caregiver follow-through. Despite robust education and goal setting, these variables can obscure true wound response and place clinicians at risk of appearing non-compliant with policy requirements, even when care is clinically appropriate.
 
Overall, while CMS policies and CTP LCDs are well-intentioned and grounded in evidence-based care, they do not always account for the inherent variability and constraints of post-acute and mobile wound care. This misalignment can place mobile providers in a position where delivering the right care for the patient and demonstrating regulatory compliance are not always perfectly aligned, highlighting an ongoing need for policy frameworks that better reflect real-world care delivery models. 
 
As you mentioned, CTP policies often assume ideal documentation workflows and clinical infrastructure. From your experience in mobile care, what compliance requirements are most difficult to operationalize—and what practical adjustments would make them more workable without compromising oversight?
 
CTP policies are largely written around an assumption of stable infrastructure and tightly integrated documentation workflows. In mobile wound care, those assumptions rarely hold true. Some of the most difficult requirements to operationalize are maintaining consistent medical necessity documentation over time, aligning reassessments with episode-of-care expectations, and tracking appropriate product utilization when care is delivered across multiple settings and platforms.
 
While technology, including newer AI-driven documentation tools, has improved data capture, it hasn’t solved the core compliance challenge. These tools still depend on someone understanding how clinical decisions, workflows, and regulatory expectations intersect in real practice. Without that clinical interpretation, documentation may be technically complete but still misaligned with policy intent, leaving practices vulnerable during audits.
 
From a practical standpoint, one of the most effective adjustments is the integration of a clinical case manager–type role. This position provides continuity across care delivery, documentation, and technology, ensuring that workflows remain defensible, reassessments are meaningful, and CTP use is supported throughout the course of treatment. Rather than reducing oversight, this kind of role strengthens compliance by translating policy into sustainable, real-world practice. 
 
As CMS continues to refine utilization controls, evidence thresholds, and payment models for CTPs, what upcoming changes concern you most for mobile wound care?
 
As CMS continues to refine utilization controls, evidence thresholds, and payment models for CTPs, my greatest concern for mobile wound care is not the regulations themselves—but how practices respond to them.
 
We’ve seen this cycle before. Each wave of reimbursement or policy change pulls provider attention toward compliance mechanics, sometimes at the expense of building the clinical workflows and wound-management competencies that actually make a practice sustainable and defensible. When those fundamentals are missing, regulations feel punitive. When they’re present, compliance tends to follow naturally.
 
The last several policy shifts around CTPs have made something painfully clear: without guardrails, some providers will exploit systems that were designed to serve one of our most vulnerable populations—post-acute patients with complex, chronic wounds. The resulting overutilization has driven the very controls we’re now reacting to: tighter LCDs, increased audits, and higher documentation thresholds.
 
What concerns me most is the risk that mobile wound practices interpret upcoming changes as something to “work around,” rather than as a signal to mature. CMS is clearly pushing the field toward disciplined patient selection, longitudinal wound management, and outcomes-driven care—not episodic procedures. Practices that invest now in strong assessment processes, standardized treatment pathways, interdisciplinary coordination, and documentation that tells a clear clinical story will be far better positioned for whatever payment or utilization changes come next.
 
In many ways, this is less about what CMS is changing and more about whether mobile wound care is ready to evolve from a procedure-driven model into a truly integrated, accountable care model. The practices that make that shift won’t just survive the next round of policy changes, they’ll help define the standard going forward.

Therese Laub is the Owner of Cicerone Consultants, LLC and a Clinical Consultant for Span America North Carolina.